Therapeutics & Vaccines
Single-Domain Antibodies And Variants Thereof Against Met
WARF: P230175US02
Inventors: Andrew Baschnagel, Randall Kimple, Reinier Hernandez, Aaron LeBeau
The Invention
UW-Madison researchers have developed a novel camelid antibody against the cancer target cMET. As cMET is overexpressed on many tumors, this antibody may be useful for imaging tumors and/or delivering therapeutics to tumor cells.
The inventors have validated the antibody for target binding, conjugated the antibody to a radioactive molecule for cancer imaging in a preclinical animal model for cancer, and is being studied for its ability to decrease cMET activity.
Additional Information
For More Information About the Inventors
For current licensing status, please contact Rafael Diaz at [javascript protected email address] or 608-960-9847